Literature DB >> 17577117

Presentation and management of pancreatic cystic neoplasms.

Stavros Gourgiotis1, Stylianos Germanos, Marco Pericoli Ridolfini.   

Abstract

Pancreatic cystic neoplasms are less frequent than other pancreatic tumors, but because of the wide availability and improvement of modern imaging methods, these neoplasms are being recognized with increasing frequency and it is often possible to be differentiated preoperatively not only from other cystic pancreatic disorders but also from one another. Most patients have no symptoms while clinical signs are not really useful in the clinical work up, and when they are present, they never help us to identify the type of pathology. Treatment differs with the diagnosis. Serous cystic neoplasms are uniformly benign and usually do not mandate resection unless this lesion is symptomatic. In contrast, mucinous cystic neoplasms and intraductal papillary mucinous neoplasms have a premalignant or malignant tendency, and therefore should be managed aggressively by pancreatic resection; in the absence of invasive disease, prognosis is excellent after appropriate surgery, but the presence of invasive malignancy signifies a poor prognosis. Solid pseudopapillary neoplasms have nonaggressive behavior and their management is related to the extension of the disease. The purpose of this article is to review the types of pancreatic cystic neoplasms, their diagnosis, indications for surgical treatment, and outcome.

Entities:  

Mesh:

Year:  2007        PMID: 17577117     DOI: 10.1097/01.mcg.0000225684.29841.52

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  6 in total

Review 1.  To cease or 'de-cyst'? The evaluation and management of pancreatic cystic lesions.

Authors:  Brintha K Enestvedt; Nuzhat Ahmad
Journal:  Curr Gastroenterol Rep       Date:  2013-10

2.  Giant mucinous cystic neoplasm of the pancreas.

Authors:  Frederico Teixeira; Vitor Moutinho; Adriano Ushinohama; Eduardo Akaishi; Edivaldo Utiyama; Samir Rasslan
Journal:  J Gastrointest Surg       Date:  2009-12-04       Impact factor: 3.452

3.  A case of serous cystadenoma of the pancreas with a central stellate scar detected on contrast-enhanced ultrasound with perflubutane.

Authors:  Hirofumi Yamanishi; Tomoyuki Yokota; Nobuaki Azemoto; Masashi Hirooka; Hidehiro Murakami; Yoichi Hiasa; Bunzo Matsuura; Morikazu Onji
Journal:  Clin J Gastroenterol       Date:  2009-04-25

Review 4.  Management of mucin-producing cystic neoplasms of the pancreas.

Authors:  Stefan Fritz; Andrew L Warshaw; Sarah P Thayer
Journal:  Oncologist       Date:  2009-02-11

5.  Surveillance and management for serous cystic neoplasms of the pancreas based on total hazards-a multi-center retrospective study from China.

Authors:  Wenchuan Wu; Ji Li; Ning Pu; Gang Li; Xin Wang; Gang Zhao; Lei Wang; Xiaodong Tian; Chunhui Yuan; Yi Miao; Kuirong Jiang; Jun Cao; Xiaowu Xu; Xueli Bai; Yongsheng Yang; Fubao Liu; Xuewei Bai; Rui Kong; Zheng Wang; Deliang Fu; Wenhui Lou
Journal:  Ann Transl Med       Date:  2019-12

6.  Managing incidental pancreatic cystic neoplasms with integrated molecular pathology is a cost-effective strategy.

Authors:  Ananya Das; William Brugge; Girish Mishra; Dennis M Smith; Mankanwal Sachdev; Eric Ellsworth
Journal:  Endosc Int Open       Date:  2015-06-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.